Search results

Evidence-based recommendations on supercapsular percutaneously assisted total hip arthroplasty for osteoarthritis in adults. This involves replacing a hip using smaller cuts than are used in standard surgery.

Result type

HealthTech guidance

Published

25 May 2022

Evidence-based recommendations on swallowable gastric balloon capsules for weight loss in adults. This involves swallowing a capsule containing a balloon that is then filled with liquid to inflate it in the stomach.

Result type

HealthTech guidance

Published

18 November 2020

Evidence-based recommendations on transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia in adults. This involves electrically stimulating nerves in the throat or neck, while the person swallows. The aim is to strengthen the muscles involved in swallowing.

Result type

HealthTech guidance

Published

19 December 2018

Evidence-based recommendations on blinatumomab (Blincyto) for treating Philadelphia-chromosome-negative precursor B-cell acute lymphoblastic leukaemia in adults.

Result type

Technology appraisal guidance

Published

28 June 2017

Evidence-based recommendations on certolizumab pegol (Cimzia) for treating moderate to severe plaque psoriasis in adults.

Result type

Technology appraisal guidance

Published

17 April 2019

Evidence-based recommendations on vaginal transluminal endoscopic hysterectomy and adnexal surgery for benign gynaecological conditions. This involves removing the uterus (womb), and sometimes the fallopian tubes and ovaries, through the vagina.

Result type

HealthTech guidance

Published

25 October 2023

Evidence-based recommendations on botulinum toxin type A injections into the urethral sphincter for idiopathic chronic non-obstructive urinary retention. This involves injecting botulinum toxin type A into the urethral sphincter.

Result type

HealthTech guidance

Published

28 June 2023

Evidence-based recommendations on entecavir for treating chronic hepatitis B in adults.

Result type

Technology appraisal guidance

Published

27 August 2008

Evidence-based recommendations on axicabtagene ciloleucel (Yescarta) for treating relapsed or refractory diffuse large B-cell lymphoma after first-line chemoimmunotherapy.

Result type

Technology appraisal guidance

Published

7 June 2023

Evidence-based recommendations on deep brain stimulation for intractable trigeminal autonomic cephalalgias. This involves delivering electrical impulses to a precise area of the brain using an electrode to mask the pain.

Result type

HealthTech guidance

Published

23 March 2011

Evidence-based recommendations on filgotinib (Jyseleca) for moderate to severe rheumatoid arthritis in adults.

Result type

Technology appraisal guidance

Published

24 February 2021

Evidence-based recommendations on encorafenib (Braftovi) with binimetinib (Mektovi) for treating unresectable or metastatic BRAF V600 mutation-positive melanoma in adults.

Result type

Technology appraisal guidance

Published

27 February 2019

Evidence-based recommendations on fulvestrant (Faslodex), for treating locally advanced or metastatic breast cancer in adults.

Result type

Technology appraisal guidance

Published

14 December 2011

Evidence-based recommendations on ivabradine (Procoralan) for treating chronic heart failure in adults.

Result type

Technology appraisal guidance

Published

28 November 2012